arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Alnylam Pharmaceuticals, Inc.

ALNY Health Care Biotechnology: Pharmaceutical Preparations
$303.05
▼ -0.2% Today
as of Jun 7, 07:08 ET
Last 30 days +0.31% Apr 28 → Jun 05
$282.87 $290.02 $297.16 $304.31 $311.46 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$306.34
High
$306.71
Low
$300.50
Volume
$1M
Avg Vol
$1M
Mkt Cap
$40.7B
P/E (TTM)
340.51
Beta
52w High
$495.55
52w Low
$283.10
Div Yield
Shares Out
$132M

Overview

52-week range
$283
$496
9% of range
Avg surprise (last 1)
+56.0%
Avg reaction (last 1)
-3.1%
0% positive
Latest IV / EM
49%
EM ±6.7% · $300 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-2.21$-1.20$-0.19$0.83$1.84 Actual $-1.40Actual $-2.21Actual $1.15Actual $-0.52Actual $-0.13Actual $-0.87Actual $-0.44Est $1.00Actual $-0.51Actual $1.84 MarJunSepMarJunSepMar/2025JunSep
Revenue vs Net Income Revenue Net income
$-112M$-18M$76M$170M$264M Mar 24Jun 24Sep 24Mar 25Jun 25Sep 25

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Sep 30, 2025Sep 2025 $1.84 financials
Mon Jun 30, 2025Jun 2025 $-0.51 financials
Thu May 1, 2025Mar/2025 $-0.44 $1.00 +56.0% -3.1% earnings
Mon Sep 30, 2024Sep 2024 $-0.87 financials
Sun Jun 30, 2024Jun 2024 $-0.13 financials
Sun Mar 31, 2024Mar 2024 $-0.52 financials
Sat Sep 30, 2023Sep 2023 $1.15 financials
Fri Jun 30, 2023Jun 2023 $-2.21 financials
Fri Mar 31, 2023Mar 2023 $-1.40 financials

Financials

Income statement (quarterly)

MetricSep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
Revenue
Cost of revenue$197M$142M$70M$82M$67M$55M
Gross profit
Operating income$368M$-16M$18M$-77M$49M$-43M
Net income$251M$-66M$-57M$-112M$-17M$-66M
EPS (diluted)$1.84$-0.51$-0.44$-0.87$-0.13$-0.52

Balance sheet (quarterly)

MetricSep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
Cash & equivalents$1.49B$1.11B$1.02B$966M$1.10B$968M$682M$813M
Inventory$75M$72M$66M$79M$76M$84M$94M$89M
Total current assets$3.95B$3.64B$3.27B$3.30B$3.36B$3.17B$2.99B$2.98B
Total assets$4.85B$4.57B$4.21B$4.24B$4.21B$4.01B$3.82B$3.83B
Long-term debt
Total liabilities$4.62B$4.32B$4.10B$4.17B$4.17B$4.01B$4.04B$4.05B
Total equity$234M$251M$115M$67M$32M$-3M$-219M$-221M

Implied volatility — last 90 days

43%46%48%51%53% Jun 07 — IV 49% · EM ±6.7%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.